Eighty-Seven Patient Groups Urge Congress to Pass Legislation That Would Improve Clinical Trial Diversity
Eighty-seven organizations representing patients with chronic and acute health conditions, sent a letter to Congress today urging them to improve the diversity of enrollment in clinical trials as part of this year’s Prescription Drug User Fee Act (PDUFA) reauthorization.